Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / CALL
-
Number of holders
-
0
-
Price
-
$315.07
Significant Holders of VERTEX PHARMACEUTICALS INC - CALL as of Q1 2023
9 filings reported holding 92532F900 - VERTEX PHARMACEUTICALS INC - CALL as of Q1 2023.
VERTEX PHARMACEUTICALS INC - CALL has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of shares
.
Largest 9 shareholders include JANE STREET GROUP, LLC (92,600 shares), SG Americas Securities, LLC (88,000 shares), GROUP ONE TRADING, L.P. (74,100 shares), IMC-Chicago, LLC (43,000 shares), SIMPLEX TRADING, LLC (30,900 shares), Allianz Asset Management GmbH (7,900 shares), JPMORGAN CHASE & CO (6,900 shares), ADVISOR GROUP HOLDINGS, INC. (1 shares), and GARDA CAPITAL PARTNERS LP (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.